W. D. SUTLIFF, M.D.; J. WARREN KYLE, M.D.; JOHN L. HOBSON, M.D.
Observation of the following 25 cases of North American blastomycosis in the past seven years provided information about clinical forms of the disease and about the response to therapy. The series of cases appeared to have a more benign course than that reported by others, and the relationship of the types of cases to outcome was considered in evaluating the results of therapy. The early favorable therapeutic effects of the aromatic diamidines, stilbamidine and 2-hydroxystilbamidine, described by others, were confirmed, and observation of treated cases was extended into the second and third years after treatment.
Learn more about subscription options.
Register Now for a free account.
SUTLIFF WD, KYLE JW, HOBSON JL. NORTH AMERICAN BLASTOMYCOSIS: CLINICAL FORMS OF THE DISEASE AND TREATMENT WITH STILBAMIDINE AND 2-HYDROXYSTILBAMIDINE(NORTH AMERICAN BLASTOMYCOSIS: CLINICAL FORMS OF THE DISEASE AND TREATMENT WITH STILBAMIDINE AND 2-HYDROXYSTILBAMIDINE*). Ann Intern Med. 1954;41:89–107. doi: 10.7326/0003-4819-41-1-89
Download citation file:
Published: Ann Intern Med. 1954;41(1):89-107.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only